Arecco A, Mun B J, Mathews C K
Department of Biochemistry and Biophysics, Oregon State University, Corvallis 97331.
Mutat Res. 1988 Jul-Aug;200(1-2):165-75. doi: 10.1016/0027-5107(88)90079-6.
This paper describes a biological test of the hypothesis that one or more components of the intracellular nucleotide pool represent a significant target for the mutagenic effects of alkylating agents. In other words, we ask whether mutagenesis can occur either through alkylation of susceptible nucleotide residues in DNA, or through alkylation of a free nucleotide, followed by its incorporation into DNA. Our approach is based upon the premise that if a nucleotide pool is a mutagenic target, then transient expansion of that pool should increase the target size and enhance mutagenesis following subsequent treatment with an alkylating agent. Working either with V79 hamster lung fibroblasts or Chinese hamster embryo fibroblasts (CHEF/18), we treated cells for 30 min, under conditions that expanded one or more pools of deoxyribonucleoside triphosphates. This was followed immediately by a 30-min treatment with 0.5 mM N-methyl-N-nitrosourea. After 8 days of additional culture for recovery of cells and expression of mutations, we plated in selective media to determine the abundance of 6-thioguanine-resistant mutants in each culture. We found that conditions which expand pools of either dATP or dTTP and dGTP stimulate mutagenesis by MNU, with the degree of stimulation varying in different experiments from 2- to 6-fold. Although alternate interpretations can be entertained, the data are consistent with the hypothesis that nucleotide pools represent alkylation targets. A biochemical test of the hypothesis is warranted. During our studies we made several other noteworthy observations: (1) treatment of V79 cells with mutagen alone does not significantly affect dNTP pools; (2) deoxynucleotide pool perturbations are quite short-lived following transfer of cells to normal medium; (3) deoxyuridine is significantly more effective than thymidine in expanding dTTP pools; (4) deoxyuridine by itself is significantly mutagenic, particularly to CHEF/18 cells.
本文描述了一项生物学试验,该试验针对的假设是细胞内核苷酸池的一个或多个组分是烷化剂诱变作用的重要靶点。换句话说,我们要问诱变是否可通过DNA中敏感核苷酸残基的烷基化发生,或者通过游离核苷酸的烷基化,随后其掺入DNA而发生。我们的方法基于这样一个前提:如果核苷酸池是诱变靶点,那么该池的短暂扩张应会增加靶点大小,并在随后用烷化剂处理后增强诱变作用。我们使用V79仓鼠肺成纤维细胞或中国仓鼠胚胎成纤维细胞(CHEF/18),在能使一个或多个脱氧核糖核苷三磷酸池扩张的条件下,将细胞处理30分钟。紧接着用0.5 mM N-甲基-N-亚硝基脲处理30分钟。在额外培养8天以使细胞恢复并表达突变后,我们接种于选择性培养基中,以确定每种培养物中6-硫鸟嘌呤抗性突变体的丰度。我们发现,使dATP池或dTTP和dGTP池扩张的条件会刺激MNU诱变,不同实验中的刺激程度在2至6倍之间变化。尽管可以有其他解释,但这些数据与核苷酸池代表烷基化靶点的假设一致。有必要对该假设进行生化试验。在我们的研究过程中,我们还做了其他一些值得注意的观察:(1)单独用诱变剂处理V79细胞不会显著影响dNTP池;(2)将细胞转移到正常培养基后,脱氧核苷酸池的扰动持续时间很短;(3)脱氧尿苷在扩张dTTP池方面比胸苷有效得多;(4)脱氧尿苷本身具有显著的诱变性,尤其是对CHEF/18细胞。